Genetic pre-screening for glaucoma in population-based epidemiology: protocol for a double-blind prospective screening study within Lifelines (EyeLife).

Anna NeustaeterIlja NolteHarold SniederNomdo M Jansonius

Published in: BMC ophthalmology (2021)

Ethics approval was obtained on January 31, 2019, and the study was retrospectively registered with the Netherlands Trial Register ( NL8718 ) on the 17th of June, 2020.

Keyphrases

public health
risk factors
genome wide
phase iii
copy number
optical coherence tomography